Montelukast API Market is growing with 9.8% CAGR: Statistics Report by Credence Research

September 26 19:25 2022
Montelukast API Market is growing with 9.8% CAGR: Statistics Report by Credence Research
Some of the major players in the market are Cipla Ltd, Merck & Co. Inc, Morepen Laboratories, Sun Pharma, Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd, Apotex, Inc, Sanyo Chemical Industries Ltd, Mylan N.V., and Delmar Chemicals Inc.

The latest market report published by Credence Research, Inc. isGlobal Montelukast API Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028”. The Global Montelukast API Market generated revenue of around USD ()  billion in 2021 and is anticipated to grow a CAGR of over 9.8% during the forecast period from 2022 to 2028 to reach around USD () billion in 2028.

Montelukast is a leukotriene inhibitor used to prevent asthma attacks in children and adults over the age of two. It also prevents exercise-induced bronchoconstriction, hay fever, allergic rhinitis, and primary dysmenorrhea. Montelukast can assist in reducing the number of times medication is used for immediate relief. One of the main factors driving the global montelukast API market is the prevalence of diseases like exercise-induced bronchospasm, urticaria, primary dysmenorrhea, allergic rhinitis, and asthma. Asthma affects approximately 235 million people worldwide, according to World Health Organization. In low- and lower-middle-income nations, over 80% of asthma-related fatalities occur. An increase in patients drives demand for montelukast sodium. However, adverse effects such as heartburn, discomfort, upset stomach, diarrhea, and nausea are expected to impede the global market growth.

Access complete report with (Drivers of growth, Forecasts, Covid Impact, Revenue, Market share, Players). Please visit: https://www.credenceresearch.com/report/montelukast-api-market

The global montelukast API market is bifurcated into Product Type, Dosage Form, Application, and Geography. Based on product type, the market is categorized into montelukast sodium amorphous and crystalline. Based on dosage form, the global market is segmented into tablets, chewable tablets, and oral solutions. Based on application, the market is categorized into asthma, allergic rhinitis, urticaria, bronchospasm, and others. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

North America dominated the global montelukast API market in 2021, owing to the presence of top companies, the high prevalence of asthma and other respiratory illnesses, and the region’s well-established health care infrastructure. Furthermore, government efforts and increased research collaborations are expected to drive the region’s market during the forecast period. In North America, the U.S. held the largest market share in 2021 due to favorable healthcare regulations, a large patient population, and advanced healthcare facilities and infrastructure.

Why to Buy This Report-

  • The report analyses the global montelukast API market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics from 2016 to 2020, with the base year of 2021 and a forecast period of 2022-2028.
  • The report includes competitive landscape information, such as how the market’s key players operate at the global, regional, and country levels.
  • In-depth analysis of the global montelukast API market segmentation by idler type, weighing capacity, and end-user industry.
  • The report includes extensive and authentic data for all factors, such as supply and demand, CAGR, consumer purchasing trends, and several others.
  • The global montelukast API market report includes global, regional, and country-level market analysis, key market trends, major players analysis, market growth strategies, and key application areas.

Table of Content-

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Research Methodology

1.3.1. Phase I – Secondary Research

1.3.2. Phase II – Primary Research

1.3.3. Phase III – Expert Panel Review

1.3.4. Approach Adopted

1.3.4.1. Top-Down Approach

1.3.4.2. Bottom-Up Approach

1.3.5. Assumptions

1.4. Market Segmentation

 

2. Executive Summary

2.1. Market Snapshot: Global Montelukast API Market

2.2. Global Montelukast API Market, By Product Type

2.3. Global Montelukast API Market, By Dosage Form

2.4. Global Montelukast API Market, By Application

2.5. Global Montelukast API Market, By Region

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Montelukast API Market Value, 2016-2028, (US$ Bn)

3.2. Market Dynamics

3.2.1. Key Growth Trends

3.2.2. Market Drivers

3.2.3. Market Restraints

3.2.4. Market Opportunities

3.2.5. Major Industry Challenges

3.3. Attractive Investment Proposition,2021

3.3.1. Product Type

3.3.2. Dosage Form

3.3.3. Application

3.3.4. Geography

 

4. Premium Insights

4.1. STAR (Situation, Task, Action, Results) Analysis

4.2. Porter’s Five Forces Analysis

4.2.1. Threat of New Entrants

4.2.2. Bargaining Power of Buyers/Consumers

4.2.3. Bargaining Power of Suppliers

4.2.4. Threat of Substitute Types

4.2.5. Intensity of Competitive Rivalry

4.3. Value Chain Analysis

4.4. Technology Analysis

4.5. Marketing Strategy Analysis

4.5.1. Direct Marketing

4.5.2. Indirect Marketing

4.5.3. Marketing Channel Development Trend

 

5. Market Positioning of Key Players, 2021

5.1. Company market share of key players, 2021

5.2. Competitive Benchmarking

5.3. Market Positioning of Key Vendors

5.4. Geographical Presence Analysis

5.5. Major Strategies Adopted by Key Players

5.5.1. Key Strategies Analysis

5.5.2. Mergers and Acquisitions

5.5.3. Partnerships

5.5.4. Product Launch

5.5.5. Geographical Expansion

5.5.6. Others

 

6. COVID 19 Impact Analysis

6.1. Global Montelukast API Market Pre Vs Post COVID 19, 2019 – 2028

6.2. Impact on Import & Export

6.3. Impact on Demand & Supply

 

7. Global Montelukast API Market

7.1. Global Montelukast API Market, by Product Type, 2016-2028(US$ Bn)

7.1.1. Overview

7.1.2. Global Montelukast API Market, By Product Type, 2021 vs 2028 (in%)

7.1.3. Global Montelukast API Market, By Montelukast Sodium Amorphous, 2016-2028 (US$ Bn)

7.1.4. Global Montelukast API Market, By Montelukast Sodium Crystalline, 2016-2028 (US$ Bn)

7.2. Global Montelukast API Market, by Dosage Form, 2016-2028(US$ Bn)

7.2.1. Overview

7.2.2. Global Montelukast API Market, By Dosage Form, 2021 vs 2028 (in%)

7.2.3. Global Montelukast API Market, By Tablet, 2016-2028 (US$ Bn)

7.2.4. Global Montelukast API Market, By Chewable Tablet, 2016-2028 (US$ Bn)

7.2.5. Global Montelukast API Market, By Oral Solution, 2016-2028 (US$ Bn)

7.3. Global Montelukast API Market, by Application, 2016-2028(US$ Bn)

7.3.1. Overview

7.3.2. Global Montelukast API Market, By Application, 2021 vs 2028 (in%)

7.3.3. Global Montelukast API Market, By Asthma, 2016-2028 (US$ Bn)

7.3.4. Global Montelukast API Market, By Allergic Rhinitis, 2016-2028 (US$ Bn)

7.3.5. Global Montelukast API Market, By Urticaria, 2016-2028 (US$ Bn)

7.3.6. Global Montelukast API Market, By Bronchospasm, 2016-2028 (US$ Bn)

7.3.7. Global Montelukast API Market, By Others, 2016-2028 (US$ Bn)

 

8. North America Montelukast API Market Analysis

………….

 

9. Europe Montelukast API Market Analysis

……………

 

10. Asia Pacific Montelukast API Market Analysis

10.1. Asia Pacific Montelukast API Market, by Product Type, 2016-2028(US$ Bn)

10.1.1. Overview

10.1.2. SRC Analysis

10.2. Asia Pacific Montelukast API Market, by Dosage Form, 2016-2028(US$ Bn)

10.2.1. Overview

10.2.2. SRC Analysis

10.3. Asia Pacific Montelukast API Market, by Application, 2016-2028(US$ Bn)

10.3.1. Overview

10.3.2. SRC Analysis

10.4. Asia Pacific Montelukast API Market, by Country, 2016-2028 (US$ Bn)

10.4.1. China

10.4.1.1. China Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

10.4.1.2. China Montelukast API, By Product Type, 2016-2028 (US$ Bn)

10.4.1.3. China Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

10.4.1.4. China Montelukast API, By Application, 2016-2028 (US$ Bn)

10.4.2. Japan

10.4.2.1. Japan Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

10.4.2.2. Japan Montelukast API, By Product Type, 2016-2028 (US$ Bn)

10.4.2.3. Japan Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

10.4.2.4. Japan Montelukast API, By Application, 2016-2028 (US$ Bn)

10.4.3. India

10.4.3.1. India Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

10.4.3.2. India Montelukast API, By Product Type, 2016-2028 (US$ Bn)

10.4.3.3. India Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

10.4.3.4. India Montelukast API, By Application, 2016-2028 (US$ Bn)

10.4.4. South Korea

10.4.4.1. South Korea Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

10.4.4.2. South Korea Montelukast API, By Product Type, 2016-2028 (US$ Bn)

10.4.4.3. South Korea Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

10.4.4.4. South Korea Montelukast API, By Application, 2016-2028 (US$ Bn)

10.4.5. South-East Asia

10.4.5.1. South-East Asia Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

10.4.5.2. South-East Asia Montelukast API, By Product Type, 2016-2028 (US$ Bn)

10.4.5.3. South-East Asia Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

10.4.5.4. South-East Asia Montelukast API, By Application, 2016-2028 (US$ Bn)

10.4.6. Rest of Asia Pacific

10.4.6.1. Rest of Asia Pacific Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

10.4.6.2. Rest of Asia Pacific Montelukast API, By Product Type, 2016-2028 (US$ Bn)

10.4.6.3. Rest of Asia Pacific Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

10.4.6.4. Rest of Asia Pacific Montelukast API, By Application, 2016-2028 (US$ Bn)

 

11. Latin America Montelukast API Market Analysis

11.1. Latin America Montelukast API Market, by Product Type, 2016-2028(US$ Bn)

11.1.1. Overview

11.1.2. SRC Analysis

11.2. Latin America Montelukast API Market, by Dosage Form, 2016-2028(US$ Bn)

11.2.1. Overview

11.2.2. SRC Analysis

11.3. Latin America Montelukast API Market, by Application, 2016-2028(US$ Bn)

11.3.1. Overview

11.3.2. SRC Analysis

11.4. Latin America Montelukast API Market, by Country, 2016-2028 (US$ Bn)

11.4.1. Brazil

11.4.1.1. Brazil Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

11.4.1.2. Brazil Montelukast API, By Product Type, 2016-2028 (US$ Bn)

11.4.1.3. Brazil Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

11.4.1.4. Brazil Montelukast API, By Application, 2016-2028 (US$ Bn)

11.4.2. Mexico

11.4.2.1. Mexico Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

11.4.2.2. Mexico Montelukast API, By Product Type, 2016-2028 (US$ Bn)

11.4.2.3. Mexico Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

11.4.2.4. Mexico Montelukast API, By Application, 2016-2028 (US$ Bn)

11.4.3. Rest of Latin America

11.4.3.1. Rest of Latin America Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

11.4.3.2. Rest of Latin America Montelukast API, By Product Type, 2016-2028 (US$ Bn)

11.4.3.3. Rest of Latin America Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

11.4.3.4. Rest of Latin America Montelukast API, By Application, 2016-2028 (US$ Bn)

 

12. Middle East and Africa Montelukast API Market Analysis

12.1. Middle East and Africa Montelukast API Market, by Product Type, 2016-2028(US$ Bn)

12.1.1. Overview

12.1.2. SRC Analysis

12.2. Middle East and Africa Montelukast API Market, by Dosage Form, 2016-2028(US$ Bn)

12.2.1. Overview

12.2.2. SRC Analysis

12.3. Middle East and Africa Montelukast API Market, by Application, 2016-2028(US$ Bn)

12.3.1. Overview

12.3.2. SRC Analysis

12.4. Middle East and Africa Montelukast API Market, by Country, 2016-2028 (US$ Bn)

12.4.1. GCC Countries

12.4.1.1. GCC Countries Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

12.4.1.2. GCC Countries Montelukast API, By Product Type, 2016-2028 (US$ Bn)

12.4.1.3. GCC Countries Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

12.4.1.4. GCC Countries Montelukast API, By Application, 2016-2028 (US$ Bn)

12.4.2. South Africa

12.4.2.1. South Africa Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

12.4.2.2. South Africa Montelukast API, By Product Type, 2016-2028 (US$ Bn)

12.4.2.3. South Africa Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

12.4.2.4. South Africa Montelukast API, By Application, 2016-2028 (US$ Bn)

12.4.3. Rest of Middle East and Africa

12.4.3.1. Rest of Middle East and Africa Montelukast API Market Estimates and Forecast, 2016-2028 (US$ Bn)

12.4.3.2. Rest of Middle East and Africa Montelukast API, By Product Type, 2016-2028 (US$ Bn)

12.4.3.3. Rest of Middle East and Africa Montelukast API, By Dosage Form, 2016-2028 (US$ Bn)

12.4.3.4. Rest of Middle East and Africa Montelukast API, By Application, 2016-2028 (US$ Bn)

 

13. Company Profiles

13.1. Merck & Co. Inc

13.1.1. Company Overview

13.1.2. Products/Services Portfolio

13.1.3. Geographical Presence

13.1.4. Financial Summary

13.1.4.1. Market Revenue and Net Profit (2019-2021)

13.1.4.2. Business Segment Revenue Analysis

13.1.4.3. Geographical Revenue Analysis

13.2. Cipla Limited

13.3. Morepen Laboratories

13.4. Sun Pharma

13.5. Teva Pharmaceutical Industries Ltd.

13.6. Intas Pharmaceuticals Ltd.

13.7. Apotex Inc

13.8. Sanyo Chemical Industries Ltd.

13.9. Mylan N.V.

13.10. Delmar Chemicals Inc.

13.11. Others

Access complete report with (Drivers of growth, Forecasts, Covid Impact, Revenue, Market share, Players). Please visit: https://www.credenceresearch.com/report/montelukast-api-market

 About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, nonlegislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Top Selling Reports @

Ophthalmic Drugs Market By Prescription Type (Prescription Ophthalmic Drugs, OTC), By Therapeutics (Glaucoma, Retinal Disorder, Dry Eye, Allergic Conjunctivitis) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

Allergy Diagnostics And Treatment Market By Product Type (Assay Kits, Consumables, Services), By Test Type (In Vivo Tests, In Vitro Tests), By Treatment Type (Antihistamines, Autoinjectable Epinephrine, Corticosteroids, Decongestants, Immuno Modulators, Immunotherapy, Leukotriene Inhibitors, Mast Cell Stabilizers, Nasal Anticholinergics), By Allergen Type (Food Allergen, Inhaled Allergen, Drug Allergen, Other Allergen) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Media Contact
Company Name: Credence Research
Contact Person: Gunakesh Parmar
Email: Send Email
Phone: +91-8668442535
City: Gwalior
State: MP
Country: India
Website: https://www.credenceresearch.com/

  Categories: